Endogenous Stem Cell-Based Brain Remodeling in Mammals

  • Marie-Pierre Junier
  • Steven G. Kernie

Part of the Stem Cell Biology and Regenerative Medicine book series (STEMCELL)

Table of contents

  1. Front Matter
    Pages i-viii
  2. Marie-Pierre Junier, Steven G. Kernie
    Pages 1-3
  3. Constantino Sotelo, Isabelle Dusart
    Pages 5-41
  4. Bobbi Fleiss, Vibol Chhor, Luigi Titomanlio, Stéphane Auvin, Olivier Baud, Pierre Gressens
    Pages 43-56
  5. Sue Hong, Tzong-Shiue Yu, Steven G. Kernie
    Pages 57-85
  6. Jean-Marie Mangin
    Pages 137-158
  7. Nathalie Lefort, Marc Peschanski
    Pages 177-198
  8. Elias A. El-Habr, Marie-Pierre Junier
    Pages 199-226
  9. Back Matter
    Pages 227-230

About this book

Introduction

This book uses the juvenile mammalian brain as a starting point to describe how different injury mechanisms influence neuronal and glial progenitor response to injury, and how in certain circumstances, these cells might play adaptive or harmful roles in recovery.  It also provides an overview of emerging concepts in progenitor biology and how current understanding of the processes regulating these cells has tempered some of the initial enthusiasm regarding their therapeutic potential. Only recently has significant effort been devoted to the study of late neurogenesis in mammals, though this interesting phenomenon was first described over fifty years ago.  In many settings, injury accelerates the ongoing neurogenesis now known to occur, and recently described reservoirs of glial progenitors add to the pool of existing reparative possibilities. 

Dr. Steven G. Kernie is an Associate Professor of Pediatrics and Pathology & Cell Biology at Columbia University in New York and Chief of Critical Care Medicine at Morgan Stanley Children’s Hospital at Columbia University Medical Center. His laboratory is interested in how the brain repairs itself following injury. The presence of adult neural stem and progenitor cells in the mammalian brain has awakened new interest and optimism in potential treatment for a variety of acquired brain disorders. The Kernie lab is investigating how adult neural stem and progenitor cells participate in injury-induced remodeling and in identifying genes and drugs that might be important in augmenting their contribution. In order to do this, they have generated a variety of transgenic mice that allow for temporally controlled alterations in the endogenous stem cell population in order to optimize the post-injury remodeling that occurs.

Dr. Marie-Pierre Junier is Research Director at Inserm and co-PI of team Glial Plasticity for the Center of Research Neuroscience Paris Seine at the University Pierre et Marie Curie. Her team showed the permissiveness of astrocytes to re-programming into immature states akin to neural progenitors or neural stem cells. It further demonstrated that these plastic capabilities of astrocytes sensitize them to cancerous transformation. The team is now using cancer stem cells isolated from human adult and pediatric gliomas to understand their differences from normal human neural stem cells. Combining proteomic, metabolic and epigenetic approaches, the team aims at developing new therapeutic strategies against these devastating cancers.

Keywords

NG2 neurogenesis oligodendrocytes oncogenesis progenitors

Editors and affiliations

  • Marie-Pierre Junier
    • 1
  • Steven G. Kernie
    • 2
  1. 1.French Institute of Health and Medical Research U1130, French National Center for Scientific ResearchPierre-and-Marie-Curie UniversityParisFrance
  2. 2.Departments of Pediatrics and Pathology & Cell BiologyColumbia University College of Physicians and SurgeonsNew YorkUSA

Bibliographic information

  • DOI https://doi.org/10.1007/978-1-4899-7399-3
  • Copyright Information Springer Science+Business Media New York 2014
  • Publisher Name Springer, Boston, MA
  • eBook Packages Biomedical and Life Sciences
  • Print ISBN 978-1-4899-7398-6
  • Online ISBN 978-1-4899-7399-3
  • Series Print ISSN 2196-8985
  • Series Online ISSN 2196-8993
  • About this book
Industry Sectors
Biotechnology
Pharma